Pendetide
Capromab Pendetide is an FDA-approved imaging agent for detecting soft tissue metastases in prostate cancer. It consists of the monoclonal antibody Capromab conjugated to the chelator Pendetide, which binds the radioisotope Indium-111. This radiopharmaceutical is used in clinical and research settings for in vivo imaging of prostate-specific membrane antigen (PSMA) .
Product Specifications
Molecular Weight
741.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
033373-APC 200 µL
CCNB1, ID (CCNB1, CCNB, G2/mitotic-specific cyclin-B1) (APC) discontinued
Sign In for Pricing
View Details AE35651MO-01 48 Tests
Mouse Leucine-rich repeat LGI family member 3 (LGI3) ELISA Kit
Sign In for Pricing
View Details